Clinical Trial Update: Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial evaluating the efficacy and safety of GSK1070806 in obese adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK1070806

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED